| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SESN | Sesen Bio, Inc. | Sullivan Mark | General Counsel & Secretary | Mar 02, 2023 | Option Exercise | $0.59 | 517,393 | 303,710 | 423,530 | Mar 06, 2023, 08:46 PM | |
| SESN | Sesen Bio, Inc. | MacDonald Glen C | Chief Technology Officer | Mar 02, 2023 | Sale | $0.59 | 456,664 | 268,062 | 432,806 | Mar 06, 2023, 08:45 PM | |
| SESN | Sesen Bio, Inc. | Ryu Elly | Principal Accounting Officer | Mar 02, 2023 | Sale | $0.59 | 17,289 | 10,149 | 148,624 | Mar 06, 2023, 08:44 PM | |
| SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Mar 02, 2023 | Sale | $0.59 | 1,094,287 | 642,346 | 950,950 | Mar 06, 2023, 08:43 PM | |
| SESN | Sesen Bio, Inc. | Forbes Monica | Chief Financial Officer | Mar 02, 2023 | Sale | $0.59 | 716,974 | 420,864 | 603,968 | Mar 06, 2023, 08:41 PM | |
| SESN | Sesen Bio, Inc. | Sullivan Mark | General Counsel & Secretary | Feb 21, 2023 | Sale | $0.59 | 39,831 | 23,393 | 299,694 | Feb 23, 2023, 07:38 PM | |
| SESN | Sesen Bio, Inc. | Ryu Elly | Principal Accounting Officer | Feb 21, 2023 | Sale | $0.59 | 7,159 | 4,204 | 165,913 | Feb 23, 2023, 07:36 PM | |
| SESN | Sesen Bio, Inc. | Cannell Thomas R | President and CEO | Feb 21, 2023 | Sale | $0.59 | 53,727 | 31,554 | 553,073 | Feb 23, 2023, 07:35 PM | |
| SESN | Sesen Bio, Inc. | Forbes Monica | Chief Financial Officer | Feb 21, 2023 | Sale | $0.59 | 61,862 | 36,332 | 480,388 | Feb 23, 2023, 07:33 PM | |
| SESN | Sesen Bio, Inc. | MacDonald Glen C | Chief Technology Officer | Feb 21, 2023 | Sale | $0.59 | 25,927 | 15,227 | 282,998 | Feb 23, 2023, 07:31 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | MCCABE JOHN J | Chief Financial Officer | Feb 14, 2017 | Sale | $2.10 | 1,399 | 2,938 | 5,930 | Feb 16, 2017, 05:09 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Celniker Abbie | Director | Sep 28, 2016 | Sale | $3.00 | 10,031 | 30,093 | 409,915 | Sep 30, 2016, 04:12 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund IV, L.P. | 10% Owner | Sep 22, 2016 | Sale | $3.17 | 376,351 | 1,194,442 | 668,912 | Sep 26, 2016, 04:03 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund IV General Partner LLC | 10% Owner | Sep 23, 2016 | Sale | $3.11 | 67,071 | 208,856 | 468,063 | Sep 26, 2016, 04:03 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund IV, L.P. | 10% Owner | Sep 21, 2016 | Sale | $3.75 | 322,723 | 1,210,211 | 781,643 | Sep 21, 2016, 05:37 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures 2007 General Partner LLC | 10% Owner | Sep 19, 2016 | Sale | $3.31 | 9,700 | 32,107 | 1,082,996 | Sep 21, 2016, 05:37 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | KANIA EDWIN M JR | 10% Owner | Sep 20, 2016 | Sale | $3.39 | 53,917 | 182,779 | 1,039,857 | Sep 21, 2016, 05:37 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | AFEYAN NOUBAR | 10% Owner | Sep 14, 2016 | Sale | $4.18 | 44,011 | 183,966 | 1,092,902 | Sep 16, 2016, 04:15 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund IV General Partner LLC | 10% Owner | Sep 15, 2016 | Sale | $4.16 | 2,681 | 11,153 | 1,090,757 | Sep 16, 2016, 04:15 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund IV General Partner LLC | 10% Owner | Sep 06, 2016 | Sale | $4.63 | 35,770 | 165,615 | 1,886,787 | Sep 08, 2016, 06:53 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Flagship Ventures Fund 2007, L.P. | 10% Owner | Sep 07, 2016 | Sale | $4.51 | 93,727 | 422,709 | 1,833,802 | Sep 08, 2016, 06:53 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | MCCABE JOHN J | Chief Financial Officer | Aug 15, 2016 | Sale | $4.80 | 1,170 | 5,616 | 7,329 | Aug 17, 2016, 07:07 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | Tubridy Karen L | Chief Development Officer | Jun 27, 2016 | Sale | $2.08 | 4,372 | 9,094 | 32,753 | Jun 29, 2016, 04:16 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Celniker Abbie | President and CEO | Jun 27, 2016 | Sale | $2.08 | 10,029 | 20,860 | 419,946 | Jun 29, 2016, 04:14 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | LEWIS JOSEPH | 10% Owner | Jun 13, 2016 | Sale | $2.74 | 1,042,000 | 2,859,352 | 1,390,712 | Jun 14, 2016, 05:24 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | MCCABE JOHN J | Senior Vice President, Finance | Feb 16, 2016 | Sale | $0.27 | 1,501 | 405 | 8,499 | Feb 17, 2016, 05:04 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Tubridy Karen L | Chief Development Officer | Dec 28, 2015 | Sale | $2.85 | 4,427 | 12,617 | 32,973 | Dec 30, 2015, 04:04 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Furfine Eric Steven | Chief Scientific Officer | Dec 28, 2015 | Sale | $2.85 | 4,652 | 13,258 | 34,648 | Dec 30, 2015, 04:03 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | Celniker Abbie | President and CEO | Dec 28, 2015 | Sale | $2.85 | 10,155 | 28,942 | 429,975 | Dec 30, 2015, 04:02 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | May 08, 2015 | Sale | $13.23 | 33,400 | 441,882 | 1,923,226 | May 11, 2015, 02:43 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 27, 2015 | Sale | $11.66 | 2,200 | 25,652 | 1,956,626 | Feb 09, 2015, 08:53 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Feb 02, 2015 | Sale | $11.62 | 17,900 | 207,998 | 1,958,826 | Feb 03, 2015, 04:34 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 28, 2015 | Sale | $11.58 | 5,000 | 57,900 | 2,091,726 | Jan 30, 2015, 05:56 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 29, 2015 | Sale | $11.46 | 55,000 | 630,300 | 2,036,726 | Jan 30, 2015, 05:56 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 30, 2015 | Sale | $11.77 | 60,000 | 706,200 | 1,976,726 | Jan 30, 2015, 05:56 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 23, 2015 | Sale | $11.88 | 5,000 | 59,408 | 2,102,926 | Jan 26, 2015, 05:46 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 26, 2015 | Sale | $11.74 | 1,300 | 15,260 | 2,097,826 | Jan 26, 2015, 05:46 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 21, 2015 | Sale | $11.57 | 1,300 | 15,041 | 2,108,626 | Jan 23, 2015, 08:44 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 22, 2015 | Sale | $11.89 | 5,000 | 59,450 | 2,107,926 | Jan 23, 2015, 08:44 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 15, 2015 | Sale | $12.26 | 1,700 | 20,849 | 2,114,726 | Jan 20, 2015, 02:33 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 16, 2015 | Sale | $12.00 | 4,400 | 52,806 | 2,109,626 | Jan 20, 2015, 02:33 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Jan 13, 2015 | Sale | $12.48 | 4,100 | 51,172 | 2,119,426 | Jan 15, 2015, 01:30 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 25, 2014 | Sale | $11.50 | 1,000 | 11,500 | 2,120,526 | Aug 27, 2014, 05:12 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 26, 2014 | Sale | $11.57 | 1,000 | 11,570 | 2,119,526 | Aug 27, 2014, 05:12 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 19, 2014 | Sale | $11.55 | 1,000 | 11,550 | 2,121,691 | Aug 21, 2014, 06:03 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 20, 2014 | Sale | $11.50 | 165 | 1,898 | 2,121,526 | Aug 21, 2014, 06:03 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 18, 2014 | Sale | $11.87 | 1,000 | 11,870 | 2,122,691 | Aug 19, 2014, 12:23 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 15, 2014 | Sale | $11.76 | 1,600 | 18,824 | 2,124,491 | Aug 19, 2014, 12:23 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 13, 2014 | Sale | $12.00 | 1,000 | 12,000 | 2,126,291 | Aug 15, 2014, 11:59 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Aug 14, 2014 | Sale | $11.50 | 1,000 | 11,501 | 2,125,296 | Aug 15, 2014, 11:59 AM | |
| EBIO | Eleven Biotherapeutics, Inc. | KANIA EDWIN M JR | 10% Owner | Feb 11, 2014 | Buy | $10.00 | 378,729 | 3,787,290 | 1,907,008 | Feb 13, 2014, 06:55 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | TEPPER ROBERT I | 10% Owner | Feb 11, 2014 | Option Exercise | $0.06 | 127,077 | 8,069 | 4,207,120 | Feb 13, 2014, 02:27 PM | |
| EBIO | Eleven Biotherapeutics, Inc. | JAFCO Super V3 Investment Limited Partnership | 10% Owner | Feb 11, 2014 | Buy | $10.00 | 219,790 | 2,197,900 | 219,790 | Feb 12, 2014, 07:25 PM |
Menu